Asthma Clinical Trial
Official title:
Children's Exposure and Health Effects From Diesel Exhaust Before and After Switch of Schoool Bus Fleets
The contribution of diesel exhaust (DE) to health, especially children's health, is of
tremendous public health interest. DE has been associated with worsening asthma and
allergies, among other important health effects. Reducing DE exposures has become a major
regulatory initiative, and federal, state, and local jurisdictions are investing hundreds of
millions of dollars in retrofitting diesel engines in school buses and other changes to
reach this goal.
The U.S. Environmental Protection Agency's recent regulations require all on-road diesel
vehicles to change to low emission engines and ultra-low-sulfur fuels by 2007 (US EPA '00).
In spring 2003, the U.S. EPA announced a nationwide voluntary school bus retrofit
initiative. In July 2003, the Washington Legislature enacted a statewide "Diesel Solutions"
program that provides 25 million dollars by 2008 to retrofit school diesel buses with
cleaner burning engines and fuels, making it one of the largest and most active voluntary
school bus retrofit program in the country. If risk assessment estimates are accurate, these
changes will have a large public health impact, especially on children who ride school buses
daily. However, no studies to-date have rigorously examined school children's exposure to
diesel exhaust (DE) and its health effects, nor such a significant change in vehicular
pollution control. We propose to seize this opportunity of a large natural experiment taking
place in the Puget Sound area and conduct a study to assess health effects from diesel bus
exhaust before and after the retrofit of diesel bus fleets between 2005 and 2007. The
specific aims of the study are to:
1. Determine whether asthmatic children changing to retrofitted buses with cleaner fuels
and engines have a reduction in sub-clinical and clinical asthma severity.
2. Determine if increased levels of DE exposure lead to an increase in acute clinical and
sub-clinical features of asthma in children.
3. Quantify the levels and changes in particle and toxic gas exposures to DE in 3 groups
of children commuting to school by retrofitted buses or private cars, old diesel buses
to be retrofitted later, and old diesel buses through the study.
Sub-aim 3: Use the time-activity information, personal exposure measurements, and on-bus
monitoring data to construct an exposure model to predict individual exposures to DE for all
subjects.
Status | Completed |
Enrollment | 450 |
Est. completion date | July 2009 |
Est. primary completion date | July 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 6 Years to 11 Years |
Eligibility |
Inclusion Criteria: - ages 6-11 and attending 1st to 5th grades at schools in one of our target districts; approximately 75% subjects will commute by bus daily, 25% commute by car/walking; - with or without physician-diagnosed asthma - If with physician-diagnosed asthma: - 1 year history, including episodic symptoms of wheezing, cough, and dyspnea; - mild intermittent (with at least one episode a week requiring inhaler), mild persistent, or moderate persistent severity of asthma by NAEPP Criteria (NHLBI '91); Exclusion Criteria: - history of smoking by the subject or by a person in the subject's home - asthma hospitalizations within 4 weeks of the start of each study year - other chronic diseases such as diabetes, congenital heart disease, chronic renal disease - new pets in the home |
Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | University of Washington Dept. Environmental and Occupational Health Sciences | Seattle | Washington |
Lead Sponsor | Collaborator |
---|---|
National Institute of Environmental Health Sciences (NIEHS) |
United States,
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|